Home » Topics » Conferences

Conferences
RSS

Neuroprotective effects of NCC-161, a new neuronal calcium antagonist

Nov. 11, 1998

Synthelabo presents new 5-HT1A inverse agonist with antagonist and anxiolytic-like activity in vivo

Nov. 11, 1998

PD-161989: novel AMPA/GLYN receptor antagonist related to PNQX

Nov. 11, 1998

Unexpected adverse events encountered with bosentan in REACH-1 trial

Nov. 11, 1998

Synthelabo presents in vitro, ex vivo and in vivo data on new MAO-B inhibitor

Nov. 11, 1998

LY-300164 protects against kainate-induced neurotoxicity in vitro in a stereoselective manner

Nov. 11, 1998

Nonpeptide CRF1 antagonist developed at Parke-Davis modulates brain NE levels

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

Knoll develops potential new antipsychotic agent with advantages over available therapies

Nov. 10, 1998

LEF-553: a potent mu-opioid receptor agonist with peripheral analgesic effects

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...